Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasms
×
Amines
×
Clear all
Filters
3
NCT02296164
2020-03-04
PROVe
Helsinn Therapeutics (U.S.), Inc
Completed
300 enrolled
7 charts